Maternal Screening Quad Marker in Marlau
Test • Include 4 Parameters
This blood test package is designed for pregnant women to assess the risk of chromosomal abnormalities and neural tube defects in the developing fetus. The test measures four biomarkers in the mother's blood and is usually done between the 15th and 20th week of pregnancy.